23 Acknowledgements
I would like to thank the following people who have kindly offered valuable feedback and suggested improvements on early drafts of this work.
Jill Feldman
Ken Kowalski (Kowalski PMetrics)
Andreas Krause (Idorsia, Basel)
David Norris (Precision Methods)
(If you would like to be added above, just send me your comments/corrections/thoughts on how to improve this work!). I appreciate I am often too “blunt”, so please tell me where I have gone too far!
I would also like to thank all my family, friends and colleagues who have encouraged me to write down my thoughts and/or improved my understanding of drug development and patient experiences.
There are many people who have inspired me. People like Lewis Sheiner, Mats Karlsson, Radford Neil and Richard McElreath to name just a few. A common attribute these people share is their willingness to share their ideas and material to engage a wider audience and initiate debate. In a very small way, I am trying to follow in their footsteps.
Most importantly, I would like to thank my wife, Camilla, and kids Emma and Casper for politely listening to me as a talk about niche areas of drug development, and allowing me the time to spend on this project. Even though I know it is very far from perfect, I am happy that I am “having a go”.
Best wishes,
Al